ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
8.70
-0.39 (-4.29%)
At close: Dec 31, 2025
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $34.27 million as of January 2, 2026. Its market cap has increased by 25.16% in one year.
Market Cap
34.27M
Enterprise Value
35.03M
Revenue
209.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$8.70
Market Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 34.27M, an increase of 1,320.13%. That is a compound annual growth rate of 12.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Glass House Brands | 710.35M |
| Elite Pharmaceuticals | 526.71M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 356.97M |
| CytoDyn | 355.55M |
| Silence Therapeutics | 287.18M |